HomeInsights52 Week Low Stocks

Shilpa Medicare Ltd 52 Week Low

Shilpa Medicare Ltd 52 Week Low

stocks purchased

₹ 2.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

28.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

YEARLOW

₹ 313.55

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Shilpa Medicare Ltd is ₹ 313.55 as of 22 Nov 24 .

Company Fundamentals for Shilpa Medicare Ltd

No data available

Market Price of Shilpa Medicare Ltd

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024911
21 Nov 2024935.8
19 Nov 2024879.9
18 Nov 2024863.4
14 Nov 2024872.9
13 Nov 2024824.75
12 Nov 2024878.05
11 Nov 2024893.2
08 Nov 2024852.7
07 Nov 2024843.4

Asset Value vs Market Value of Shilpa Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare spurts on European regulator nod for Octreotide & Nifedipine

Octreotide, a synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid-p...

Read more

19 Nov 202411:24

News

Shilpa Medicare rallies after robust Q2 results

Profit before tax (PBT) surged 300.98% to Rs 36.77 crore in Q2 FY25 over Q2 FY24. EBITDA j...

Read more

14 Nov 202410:39

News

Shilpa Medicare update on its CDMO partner - Unicycive Therapeutics

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has announced that the U.S. Food and Drug Admi...

Read more

12 Nov 202415:02

News

Shilpa Medicare schedules board meeting

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 13 Novembe...

Read more

04 Nov 202418:42

News

Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility

In a regulatory filing made during market hours today, the company informed the company's ...

Read more

31 Oct 202413:43

News

Shilpa Medicare arm gets CEP from EDQM for Desmopressin

Desmopressin is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid...

Read more

04 Oct 202408:40

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Shilpa Medicare Ltd

Why is it important to track the 52-week low of Shilpa Medicare Ltd stocks?

Investors should monitor the 52-week low of Shilpa Medicare Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Shilpa Medicare Ltd stocks hitting a 52-week low?

Factors leading to Shilpa Medicare Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Shilpa Medicare Ltd stocks when they hit a 52-week low?

Buying Shilpa Medicare Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Shilpa Medicare Ltd stocks?

Investors should monitor the 52-week low of Shilpa Medicare Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Shilpa Medicare Ltd stock at their 52-week low?

An investor can analyze the reasons for the Shilpa Medicare Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Shilpa Medicare Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Shilpa Medicare Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Shilpa Medicare Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*